Rankings
▼
Calendar
SNDX FY 2011 Earnings — Syndax Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
SNDX
Syndax Pharmaceuticals, Inc.
$2B
FY 2011 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$51,000
Operating Income
-$10M
Net Income
-$13M
EPS (Diluted)
$-0.00
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$10M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$5M
Total Liabilities
$24M
Stockholders' Equity
-$19M
Cash & Equivalents
$4M
← FY 2012
All Quarters
